Although in ovarian cancer the key relationship between miR-100 and the mTOR pathway was confirmed [68], in our RCC model the tendency to increase miR-100-5p after PTEN knockout was not sufficient to change mTOR expression. The gene discussed is PTEN; the disease is renal cell carcinoma.